Skip to content

Microdosimetric characterization of a clinical helium beam using a MicroPlus-Bridge detector and a diamond detector for RBE assessment

MetadataDetails
Publication Date2025-09-17
JournalPhysics in Medicine and Biology
AuthorsGiada Petringa, C. Verona, A. Attili, Lorenzo Brighel, Roberto Catalano
InstitutionsIstituto Nazionale di Fisica Nucleare, University of Campania “Luigi Vanvitelli”
AnalysisFull AI Review Included
  • Clinical Significance: First comprehensive microdosimetric characterization of a clinical raster-scanned 4He ion beam at the Heidelberg Ion-Beam Therapy Center (HIT), validating helium-ion therapy as a precise modality for deep-seated tumors.
  • Detector Validation: A synthetic single-crystal diamond (SCD) microdosimeter demonstrated strong agreement with established silicon-on-insulator (SOI) MicroPlus-Bridge detectors across the entire spread-out Bragg peak (SOBP).
  • Biological Correlation: Modified Microdosimetric Kinetic Model (m-MKM) predictions matched experimental RBE10 values from clonogenic assays on SAOS-2 and U2OS osteosarcoma cell lines within uncertainty margins.
  • Dosimetric Range: RBE10 values ranged from ~0.9 at the beam entrance (LD ~ 4 keV µm-1) up to ~2.5 in the distal fall-off region (LD ~ 70 keV µm-1).
  • Simulation Framework: Geant4 Monte Carlo simulations using the Radiobiology extended example validated experimental lineal energy distributions for both primary and total (including secondary fragments) contributions.
  • Fabrication Method: Diamond microdosimeter fabricated via two-step Microwave Plasma-Enhanced Chemical Vapor Deposition (MWPE-CVD) on a commercial synthetic diamond substrate, operating as a boron-doped/intrinsic/metal Schottky diode.
  • Key Advantage: Narrower spectral response from the diamond slab geometry reduces energy-loss straggling artifacts compared to cylindrical silicon SVs, improving microdosimetric fidelity at high LET.
ParameterValueUnitContext
Sensitive Volume (SV) Area100 × 100µmDiamond microdosimeter planar SV
SV Thickness4.8µmDiamond microdosimeter active layer
SV Total Volume4.8 × 10-5mm3Calculated diamond SV
Polarizing Voltage+15VApplied across diamond Schottky diode
Water-Equivalent Mean Chord Length15µmDiamond SV in tissue
Water-Equivalent Mean Chord Length17.3µmSilicon (10 µm SV) in tissue
Shaping Time2µsORTEC 570 amplifier
Noise Threshold (ynoise)~1keV µm-1Electronic noise floor
Beam Energy Range89.64 - 119.15MeV u-14He energy layers (22 layers)
SOBP Field Size2 × 2cm2132 spots per energy layer
SOBP Depth in PMMA6 - 10cm4 cm modulation width
Dose Range Delivered0.5 - 4GyClonogenic assay doses
Ion Beam Intensity5 × 106ions s-1Anti-pile-up setting
Events per Measurement~2 × 105eventsStatistical robustness threshold
Positioning Uncertainty±0.20mmDepth alignment error
PMMA-to-Water Conversion Factor1.165-WET scaling ratio
LD at Beam Entrance~4keV µm-1Low-LET plateau region
LD at SOBP Fall-off~70keV µm-1High-LET distal edge
RBE10 Range (SAOS-2)1.17 - 1.57-Proximal to distal SOBP
RBE10 Range (U2OS)1.07 - 1.55-Proximal to distal SOBP
  1. Beam Delivery: Raster-scanned 4He ion beam at HIT using 22 energy layers (89.64-119.15 MeV u-1) forming a 4 cm SOBP (6-10 cm depth in PMMA); 2 × 2 cm2 field with 132 spots per layer.
  2. Treatment Planning: Raystation 11B TPS (v12.0.0.932) generated dose-optimized plans delivering 0.5-4 Gy per fraction.
  3. Detector Positioning: Perpendicular irradiation through PMMA slabs; WET derived using 1.165× relative stopping power factor; ±0.20 mm alignment tolerance.
  4. Diamond Microdosimeter Fabrication: Two-step MWPE-CVD process on synthetic diamond substrate, creating a boron-doped/intrinsic/metal Schottky diode; selective CVD defines the 100 × 100 × 4.8 µm SV.
  5. Signal Readout Chain: Charge-sensitive preamplifier (ORTEC 142) → shaping amplifier (ORTEC 570, 2 µs) → ORTEC EASY MCA; aluminum housing with 3 cm aperture for EMI shielding.
  6. Microdosimetric Conversion: Lineal energy (y) = ε / <span style=“text-decoration:overline”>l</span>; spectra rescaled by water-equivalent mean chord length (15 µm diamond, 17.3 µm silicon).
  7. Monte Carlo Validation: Geant4 v10.08.p02 with Radiobiology extended example; physics lists: G4EmStandardPhysics_option4, G4HadronPhysicsQGSP_BIC_AllHP, G4IonPhysicsPHP; 1 × 107 primary histories per run.
  8. Biological Assay: Clonogenic survival on SAOS-2 and U2OS cell lines at 66.3 mm (proximal), 77.2 mm (mid), 94.2 mm (distal) WET; 4 replicates per dose point.
  9. RBE Modeling: Modified Microdosimetric Kinetic Model (m-MKM) with saturation correction (Kase formalism); parameters: SAOS-2 (αref=0.44 Gy-1, z0=45.6 Gy, rD=0.38 µm), U2OS (αref=0.51 Gy-1, z0=57.7 Gy, rD=0.34 µm).
  • Optical Grade SCD (Single Crystal Diamond): The precise slab geometry (100 × 100 × 4.8 µm SV) and tissue-equivalent response described in this study align directly with 6CCVD’s high-purity single crystal diamond capabilities. The MWPE-CVD boron-doped/intrinsic/metal Schottky architecture is replicable using our controlled doping profiles.
  • Heavy Boron-Doped PCD: For applications requiring larger sensitive areas while maintaining radiation hardness, polycrystalline diamond with engineered boron concentration gradients offers a robust alternative.
  • Boron-Doped SCD Wafers: Custom thickness ranges (0.1 µm - 500 µm) enable optimization of the intrinsic layer for specific LET detection thresholds and charge collection efficiency.
  • Tailored SV Dimensions: The 4.8 µm thickness and 100 µm planar geometry cited here represent one optimized configuration. 6CCVD supports custom SV designs across sub-micron to millimeter scales via photolithographic patterning and selective CVD deposition.
  • Metalization Services: The boron-doped/intrinsic/metal Schottky contact can be realized using 6CCVD’s internal metalization capabilities (Au, Pt, Pd, Ti, W, Cu) to achieve desired barrier heights and radiation-hard interfaces.
  • Laser Cutting & Shaping: Custom detector housing apertures, PCB integration patterns, and die-level singulation are available for system integration into clinical or research detector assemblies.
  • Wafer-Scale Production: Plates and wafers up to 125 mm diameter (PCD) enable batch fabrication of multiple SVs on a single substrate for array-based detector systems.
  • PhD-Level Consultation: 6CCVD’s in-house engineering team assists researchers in selecting optimal diamond grades, doping concentrations, and electrode configurations for microdosimetry, beam monitoring, and radiation detection applications.
  • Material Characterization: Ra < 1 nm polishing for SCD surfaces ensures minimal charge trapping at the metal-semiconductor interface, critical for reproducible spectroscopic performance in low-noise ion beam detection.
  • Application-Specific Optimization: For particle therapy dosimetry projects, 6CCVD provides guidance on intrinsic layer thickness optimization, guard ring design, and radiation tolerance testing protocols.
  • Global Logistics: Clinical and research facilities worldwide benefit from streamlined DDU/DDP shipping options, ensuring materials arrive with full chain-of-custody documentation for regulated environments.

For custom specifications, material consultation, or prototype fabrication for your next particle therapy or microdosimetry project, visit 6ccvd.com or contact our engineering team directly.

View Original Abstract

Abstract Objective . This study aims to perform a comprehensive microdosimetric characterization of a clinical helium ion beam at the Heidelberg ion-beam Therapy center, assessing radiation quality along a spread-out Bragg peak (SOBP) and providing experimental data to support the biological effectiveness of helium ions in clinical applications. Approach . Microdosimetric spectra were measured at several water depths within the SOBP using two solid-state detectors: a silicon and a synthetic single-crystal diamond detector. Microdosimetric quantities, including dose-mean lineal energy ( <mml:math xmlns:mml=“http://www.w3.org/1998/Math/MathML” overflow=“scroll”> <mml:mrow> <mml:msub> <mml:mi>y</mml:mi> <mml:mrow> <mml:mi mathvariant=“normal”>D</mml:mi> </mml:mrow> </mml:msub> </mml:mrow> </mml:math> ) and frequency-mean lineal energy ( <mml:math xmlns:mml=“http://www.w3.org/1998/Math/MathML” overflow=“scroll”> <mml:mrow> <mml:msub> <mml:mi>y</mml:mi> <mml:mrow> <mml:mi mathvariant=“normal”>F</mml:mi> </mml:mrow> </mml:msub> </mml:mrow> </mml:math> ), were derived. Monte Carlo simulations with the Geant4 toolkit replicated the experimental setup to validate the measured quantities. The modified microdosimetric kinetic model was also applied to estimate the relative biological effectiveness at 10% survival (RBE 10 ). SAOS-2 and U2OS clonogenic assays were performed under identical irradiation conditions at the same facility to benchmark the RBE predictions. Main results . The experimental results demonstrated a progressive increase in <mml:math xmlns:mml=“http://www.w3.org/1998/Math/MathML” overflow=“scroll”> <mml:mrow> <mml:msub> <mml:mi>y</mml:mi> <mml:mrow> <mml:mi mathvariant=“normal”>D</mml:mi> </mml:mrow> </mml:msub> </mml:mrow> </mml:math> values along the beam path, peaking at the distal edge of the SOBP, consistent with the simulated dose-averaged linear energy transfer distribution. The RBE 10 values estimated by the two solid-state detectors showed good agreement with the experimental data from clonogenic assays, within the associated uncertainties. Significance . These findings underscore the utility of advanced solid-state detectors for helium beam characterization and highlight the importance of microdosimetry in improving radiobiological modeling. The results provide further evidence supporting the clinical potential of helium ion therapy, particularly for tumors requiring high precision and maximal healthy tissue sparing.

  1. 2003 - Geant4-a simulation toolkit [Crossref]
  2. 2023 - Formation of spread-out bragg peak for helium-ion beam using microdosimetric kinetic model [Crossref]
  3. 2006 - Geant4 developments and applications [Crossref]
  4. 2016 - Recent developments in Geant4 [Crossref]
  5. 2023 - Microdosimetry of a 62-mev clinical proton beam with five detectors [Crossref]
  6. 2017 - Correction factors to convert microdosimetry measurements in silicon to tissue in 12C ion therapy [Crossref]
  7. 2015 - Comparative study of dose distributions and cell survival fractions for 1H, 4He, 12C and 16O beams using Geant4 and microdosimetric kinetic model [Crossref]
  8. 2023 - Geant4-DNA simulation of human cancer cells irradiation with helium ion beams [Crossref]
  9. 2018 - A modified microdosimetric kinetic model for relative biological effectiveness calculation [Crossref]
  10. 2020 - Microdosimetry of a therapeutic proton beam with a mini-TEPC and a microplus-bridge detector for RBE assessment [Crossref]